How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,371 results for

ADHD Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Parental Perspectives on Use, Benefits, and Physician Knowledge of Complementary and Alternative Medicine in Children with Autistic Disorder and Attention-Deficit/Hyperactivity Disorder. Full Text available with Trip Pro

Parental Perspectives on Use, Benefits, and Physician Knowledge of Complementary and Alternative Medicine in Children with Autistic Disorder and Attention-Deficit/Hyperactivity Disorder. Complementary and alternative medicine (CAM) use appears to be increasing in children with developmental disorders. However, it is not clear whether parents perceive their healthcare providers as resources who are knowledgeable about CAM therapies and are interested in further developing their knowledge.(1 (...) ) To establish and compare use of, and perceived satisfaction with, traditional medicine and CAM in children with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs) and (2) to assess parental perceptions of physician knowledge of CAM and physician interest in continuing education about CAM for the two groups of parents.Families of children with a diagnosis of ADHD or ASD were surveyed regarding the frequency of use of traditional treatment and CAM, parental perceptions

2013 Journal of Alternative and Complementary Medicine

142. Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder

Intervention Model: Crossover Assignment Masking: Double (Participant, Outcomes Assessor) Primary Purpose: Treatment Official Title: Randomized Control Trial of Two Computer-Based Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder (ADHD) Study Start Date : May 2009 Actual Primary Completion Date : December 2012 Actual Study Completion Date : November 2013 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go (...) terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms

2012 Clinical Trials

143. Attention Deficit Hyperactivity Disorder (Follow-up)

with Attention-Deficit/Hyperactivity Disorder (CHADD). The NRC is a national information resource center dedicated to providing evidence-based information about ADHD to the public. If you have a question about ADHD for yourself, your child, or a family member, please contact the NRC. Call 1-800-233-4050 to speak with a knowledgeable health information specialist. Previous References Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M, et al. Is Adult ADHD a Childhood-Onset Neurodevelopmental (...) Attention Deficit Hyperactivity Disorder (Follow-up) Attention Deficit Hyperactivity Disorder (ADHD) Follow-up: Further Outpatient Care, Further Inpatient Care, Prognosis Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache

2014 eMedicine.com

144. Attention Deficit Hyperactivity Disorder (Follow-up)

. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition . Washington, DC: American Psychiatric Association; 2013. Brown TE. Brown ADD Scales. San Antonio, TX: Psychological Corp; 1996:5-6. Daley D, van der Oord S, Ferrin M, et al, for the European ADHD Guidelines Group. Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. J Am Acad Child Adolesc Psychiatry . 2014 Aug. 53(8):835-847.e5. . Brauser (...) D. Behavioral interventions effective for ADHD. Medscape Medical News . July 31, 2014. . Spinelli S, Joel S, Nelson TE, Vasa RA, Pekar JJ, Mostofsky SH. Different neural patterns are associated with trials preceding inhibitory errors in children with and without attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry . 2011 Jul. 50(7):705-715.e3. . Ducharme S, Hudziak JJ, Botteron KN, Albaugh MD, Nguyen TV, Karama S, et al. Decreased regional cortical thickness and thinning

2014 eMedicine Pediatrics

145. Treatment for Insomnia and Disrupted Sleep Behavior in Children and Adolescents with Autism Spectrum Disorder

1 2 ABC: Aberrant Behavior Checklist 3 ASD: autism spectrum disorder 4 ADHD: attention-deficit/hyperactivity disorder 5 AEs: adverse events 6 BR: bedtime resistance 7 CAM: complementary and alternative medicine 8 CBT: cognitive behavioral therapy 9 CSHQ: Children’s Sleep Habit Questionnaire 10 CSHQ-BR: Children’s Sleep Habit Questionnaire-Bed Resistance 11 CSHQ-SOD: Children’s Sleep Habit Questionnaire-Sleep Onset Delay 12 DBC: Developmental Behavior Checklist 13 FDA: Food and Drug (...) decreased awareness of social and environmental clues that help habituate sleep–wake cycles. 22 Abnormalities in GABAergic, glutamatergic, serotonergic, and dopaminergic systems in ASD 23 16 are also possible contributors. Coexisting conditions such as epilepsy, nocturnal 1 gastroesophageal reflux disorder (GERD), anxiety, depression, bipolar disorder, psychosis, and 2 attention-deficit/hyperactivity disorder (ADHD) can further contribute to sleep problems. Core 3 or co-occurring ASD symptoms

2020 American Academy of Neurology

146. Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder

Numbers: 2010-0002283 First Posted: July 31, 2013 Results First Posted: December 4, 2014 Last Update Posted: December 4, 2014 Last Verified: November 2014 Keywords provided by Jae-Won Kim, Seoul National University: ADHD ADRA2A Methylphenidate Response Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders (...) predictors of treatment response associated with NE system genes in ADHD. Condition or disease Intervention/treatment Phase Attention Deficit Hyperactivity Disorder Drug: Methylphenidate Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 83 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Basic Science Official Title: Gene-environment Interactions and Brain Functional

2013 Clinical Trials

147. An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.

Title: An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. Study Start Date : November 2013 Actual Primary Completion Date : June 2016 Actual Study Completion Date : June 2016 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Naltrexone Naltrexone Drug: Naltrexone Adults with ADHD Outcome Measures Go to Primary Outcome Measures : Change in Adult (...) MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Naltrexone Alcohol Deterrents Narcotic Antagonists Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents

2013 Clinical Trials

148. An Exploratory, Single-Blind Pilot Study Of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 SR in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

: Neurovance, Inc. ClinicalTrials.gov Identifier: Other Study ID Numbers: EB-1020-SR-ADHD-201 First Posted: September 11, 2013 Last Update Posted: November 5, 2015 Last Verified: September 2015 Keywords provided by Euthymics BioScience, Inc. ( Neurovance, Inc. ): Adult ADHD Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders (...) Of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 SR in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder Study Start Date : September 2013 Actual Primary Completion Date : February 2014 Actual Study Completion Date : February 2014 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: EB-1020 SR 100-500 mg flexible titration Drug: EB-1020 SR 100-500 mg flexible titration Placebo

2013 Clinical Trials

149. The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children

Numbers: ADHD_Omega_Exercise First Posted: March 8, 2013 Last Update Posted: March 8, 2013 Last Verified: March 2013 Keywords provided by JGalduroz, Federal University of São Paulo: Physical Training ADHD-Attention deficit hyperactivity disorder Omega 3 Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic (...) 2013 by JGalduroz, Federal University of São Paulo. Recruitment status was: Recruiting First Posted : March 8, 2013 Last Update Posted : March 8, 2013 Sponsor: Federal University of São Paulo Information provided by (Responsible Party): JGalduroz, Federal University of São Paulo Study Details Study Description Go to Brief Summary: The attention deficit hyperactivity disorder (ADHD) usually occurs in preschool and may cause disabilities through whole life. The treatment of this disease is expensive

2013 Clinical Trials

150. Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder

: Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder Study Start Date : June 2013 Actual Primary Completion Date : June 2015 Actual Study Completion Date : June 2015 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Behavioral Cognitive testing of participants. Asterisk applies for patient group. Day 1: Patient arrives having (...) Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Methylphenidate Central Nervous System Stimulants Physiological Effects of Drugs Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Dopamine Agents Neurotransmitter

2013 Clinical Trials

151. Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder

record (EHR), (3) have attention-deficit hyperactivity disorder (ADHD), and (4) are to receive treatment with stimulant medication for the first time in these practices, have superior clinical outcomes if their clinicians have access to an EHR-guided clinical decision support system (intervention group) than if their clinicians have no such access (control group). Condition or disease Intervention/treatment Phase Attention Deficit-hyperactivity Disorder Behavioral: Clinical decision support (...) -hyperactivity disorder Primary care Pediatric research network Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms

2013 Clinical Trials

152. The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.

ClinicalTrials.gov Identifier: Other Study ID Numbers: 0009-12-SHA First Posted: February 25, 2013 Last Update Posted: March 23, 2015 Last Verified: March 2015 Keywords provided by Maya Kritchman Lupo, Shalvata Mental Health Center: Attention Deficit Hyperactivity Disorder Methylphenidate Placebo State anxiety Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders (...) Provider, Investigator, Outcomes Assessor) Primary Purpose: Diagnostic Official Title: A Double Blind Randomized Crossover Study of the Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder. Study Start Date : February 2013 Estimated Primary Completion Date : October 2015 Estimated Study Completion Date : May 2016 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm

2013 Clinical Trials

153. Neurobiological Aspects of the Attention Deficit Hyperactivity Disorder

electroencephalography; Functional Brain Network; Go/No Go test. Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms (...) Party): Eduardo Pondé de Sena, Federal University of Bahia Study Details Study Description Go to Brief Summary: Evaluating neurobiological disorder associated with Attention Deficit Hyperactivity Disorder (ADHD) and the contribution of transcranial direct current stimulation (tDCS) in the adaptation of inhibitory control. Condition or disease Intervention/treatment Phase Attention Deficit Hyperactivity Disorder Device: Transcranial Direct Current Stimulation Device: Sham Not Applicable Detailed

2013 Clinical Trials

154. Developmental Origins of Attention Deficit Hyperactivity Disorder

and Science University: Attention Deficit and Hyperactivity Disorder Nutrition Diet Developmental Origins of Disease Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Hyperkinesis Impulsive Behavior Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Nutrients Growth Substances Physiological Effects of Drugs (...) : November 13, 2013 Sponsor: Oregon Health and Science University Information provided by (Responsible Party): Joel Nigg, Ph.D., Oregon Health and Science University Study Details Study Description Go to Brief Summary: This is a study evaluating the relationship between prenatal nutrition and neural development in infants born to mothers with Attention Deficit Hyperactivity Disorder (ADHD). We are hypothesizing that women randomized to a whole food, nutrient-dense diet during their 3rd trimester

2013 Clinical Trials

155. The effectiveness of police custody assessments in identifying suspects with intellectual disabilities and attention deficit hyperactivity disorder. Full Text available with Trip Pro

The effectiveness of police custody assessments in identifying suspects with intellectual disabilities and attention deficit hyperactivity disorder. Intellectual Disabilities (ID) and Attention Deficit Hyperactivity Disorder (ADHD) are recognized psychological vulnerabilities in police interviews and court proceedings in England and Wales. The aims of this study were to investigate: (a) the prevalence of ID and/or ADHD among suspects detained at a large London metropolitan police station (...) and their relationship with conduct disorder (CD), (b) the impact of their condition on police staff resources, (c) the effectiveness of current custody assessment tools in identifying psychological vulnerabilities, and (d) the use of 'Appropriate Adults' in interviews.A total of 200 individuals in a police custody suite were interviewed and screened for ID, ADHD (current symptoms) and CD.The screening rates for these three disorders were 6.7%, 23.5% and 76.3%, respectively. ADHD contributed significantly

2013 BMC Medicine

156. Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies. Full Text available with Trip Pro

Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies. Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that often persists throughout life. Approximately two-thirds of patients with a childhood diagnosis of ADHD continue to experience clinically significant symptoms into adulthood. Nevertheless, most of these individuals consider themselves "well (...) of support and schedule follow-up appointments to reassess patient status. Medication discontinuation can be used as an opportunity to help patients recognize their most impairing symptoms, learn and implement behavioral strategies to cope with ADHD symptoms, and understand when additional supportive resources and the resumption of medication management may be necessary.

2013 Therapeutics and clinical risk management Controlled trial quality: uncertain

157. The Effects of DHA on Attention Deficit and Hyperactivity Disorder

: Other Study ID Numbers: EM-00-11 First Posted: February 21, 2013 Last Update Posted: August 31, 2015 Last Verified: August 2015 Keywords provided by Maria Nobile, IRCCS Eugenio Medea: ADHD DHA neuropsychological task fNIRS Docosahexaenoic Acid n-3 polyunsaturated fatty acid cognition behavior Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders (...) oil Phase 3 Detailed Description: The primary objective of this study is to investigate the relative efficacy and tolerability of omega-3 fatty acid supplementation, more specifically docosahexaenoic acid (DHA), in reducing attention-deficit/hyperactivity disorder (ADHD) symptoms in children. The present study is going to determine whether DHA supplementation induces modifications in fatty acid blood level and to evaluate the correlation between this possible modification and behavioral

2013 Clinical Trials

158. Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia, Attention Deficit Hyperactivity Disorder and Bipolar Disorder

: Layout table for MeSH terms Disease Schizophrenia Bipolar Disorder Attention Deficit Disorder with Hyperactivity Pathologic Processes Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders Bipolar and Related Disorders Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders (...) Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia, Attention Deficit Hyperactivity Disorder and Bipolar Disorder Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2012 Clinical Trials

159. Caregiver burden as people with autism spectrum disorder and attention-deficit/hyperactivity disorder transition into adolescence and adulthood in the United kingdom. (Abstract)

Caregiver burden as people with autism spectrum disorder and attention-deficit/hyperactivity disorder transition into adolescence and adulthood in the United kingdom. There is increasing recognition that autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are associated with significant costs and burdens. However, research on their impact has focused mostly on the caregivers of young children; few studies have examined caregiver burden as children transition (...) ), primary appraisal (need), and resources (use of services).Both disorders were associated with a high level of caregiver burden, but it was significantly greater in ASD. In both groups, caregiver burden was mainly explained by the affected young person's unmet need. Domains of unmet need most associated with caregiver burden in both groups included depression/anxiety and inappropriate behavior. Specific to ASD were significant associations between burden and unmet needs in domains such as social

2012 Journal of the American Academy of Child and Adolescent Psychiatry

160. Attention Deficit Disorder

deficit d'attenzione Derived from the NIH UMLS ( ) Ontology: Attention deficit hyperactivity disorder (C1263846) Definition (MEDLINEPLUS) Is it hard for your child to sit still? Does your child act without thinking first? Does your child start but not finish things? If so, your child may have attention deficit hyperactivity disorder (ADHD). Nearly everyone shows some of these behaviors at times, but ADHD lasts more than 6 months and causes problems in school, at home and in social situations. ADHD (...) Attention Deficit Disorder Aka: Attention Deficit Disorder , Attention Deficit Hyperactivity Disorder , ADHD , Attentional Disorders , Attention Deficit Disorder in Children From Related Chapters II. Epidemiology Diagnosed at one point in up to 11% of school children ages 4 to 17 years old (1-2 per classroom) At a given time 8.8% of school children have the diagnosis and 6.1% are on medication for Attention Deficit More commonly diagnosed in boys than girls (4 - 8:1) However girls are more often

2018 FP Notebook

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>